课题基金 / 基金详情

IMIQUIMOD CREAM IN GENITAL/PERIANAL WARTS

IMIQUIMOD CREAM IN GENITAL/PERIANAL WARTS
咪奎莫德乳膏治疗生殖器/肛周疣
批准号：
3739000
负责人：
PETER G PAPPAS
金额：
$0.0万
依托单位：
UNIVERSITY OF ALABAMA AT BIRMINGHAM
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/3739000
关键词：
antiviral agents clinical trials condyloma acuminatum drug screening /evaluation human subject human therapy evaluation interferons microorganism disease chemotherapy neoplasm /cancer chemotherapy neoplasm /cancer pharmacology skin disorder chemotherapy topical drug application

项目摘要

项目成果

PETER G PAPPAS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In this multicenter, randomized, double blinded, placebo-controlled trial sponsored by 3M Pharmaceuticals, a new drug, imiquimod, a nonnucleoside compound, which has been shown to increase local interferon production when applied locally will be evaluated for safety and efficacy in the treatment of genital warts.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
INTERFERON + CRYOTHERAPY IN CONDYLOMA ACUMINATUM
HUMAN ANTI-CMV MONOCLONAL ANTIBODY IN PATIENTS WITH AIDS & CMV VIREMIA/VIRURIA
MOLECULAR EPIDEMIOLOGY OF HUMAN PAPILLOMAVIRUS IN IMMUNOSUPPRESSED WOMEN
CILOFUNGEN IN CANDIDA ESOPHAGITIS
海外基金